Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Maja Agung Latexindo TbkISX:SURI +1.49%28 ROC (Joel Greenblatt) % is 5.52% as of Mar. 2026, which is 309% above its 10-year median of 1.35. GuruFocus rates ISX:SURI with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 838 Medical Devices & Instruments companies, PT Maja Agung Latexindo Tbk ranks worse than 53.7% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. PT Maja Agung Latexindo Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 5.52%.
The historical rank and industry rank for PT Maja Agung Latexindo Tbk's ROC (Joel Greenblatt) % or its related term are showing as below:
ISX:SURI'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -5.16 Med: 1.35 Max: 63.29
Current: -0.03
During the past 6 years, PT Maja Agung Latexindo Tbk's highest ROC (Joel Greenblatt) % was 63.29%. The lowest was -5.16%. And the median was 1.35%.
ISX:SURI's ROC (Joel Greenblatt) % is ranked worse than 53.7% of 838
companies
in the Medical Devices & Instruments industry
Industry Median: 4.145
vs ISX:SURI: -0.03
PT Maja Agung Latexindo Tbk (ISX:SURI) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Maja Agung Latexindo Tbk ROC (Joel Greenblatt) % Chart
ISX:SURI vs ISRG, BDX, MDLN: ROC (Joel Greenblatt) % Comparison
For the Medical Instruments & Supplies subindustry, PT Maja Agung Latexindo Tbk's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Maja Agung Latexindo Tbk ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PT Maja Agung Latexindo Tbk's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where PT Maja Agung Latexindo Tbk's ROC (Joel Greenblatt) % falls into.
PT Maja Agung Latexindo Tbk ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 5.52% mean?
PT Maja Agung Latexindo Tbk (ISX:SURI) has a ROC (Joel Greenblatt) % of 5.52% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on PT Maja Agung Latexindo Tbk and its competitors. This is 309% above median its historical median of 1.35. According to the industry distribution chart, PT Maja Agung Latexindo Tbk ranks #450 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 53.7%.
Is PT Maja Agung Latexindo Tbk's ROC (Joel Greenblatt) % too high?
PT Maja Agung Latexindo Tbk's current ROC (Joel Greenblatt) % of 5.52% is 309% above median its 10-year median of 1.35. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.15. PT Maja Agung Latexindo Tbk's value of 5.52% is 33.2% above this industry median. Based on the distribution chart, PT Maja Agung Latexindo Tbk ranks #450 out of 838 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, PT Maja Agung Latexindo Tbk has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does PT Maja Agung Latexindo Tbk's ROC (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PT Maja Agung Latexindo Tbk ranks #450 out of 838 companies for ROC (Joel Greenblatt) %. This places PT Maja Agung Latexindo Tbk in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 4.15. PT Maja Agung Latexindo Tbk's value of 5.52% is 33.2% above this benchmark. While the company's 10-year median is 1.35 vs. the industry median of 4.15, PT Maja Agung Latexindo Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.15, based on 838 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Maja Agung Latexindo Tbk's current ROC (Joel Greenblatt) % of 5.52% is 33.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on PT Maja Agung Latexindo Tbk and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Maja Agung Latexindo Tbk's current ROC (Joel Greenblatt) % is 5.52%, which is 309% above median its own 10-year median of 1.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Maja Agung Latexindo Tbk stock overvalued right now?
PT Maja Agung Latexindo Tbk (ISX:SURI) has a current ROC (Joel Greenblatt) % of 5.52%. The current ROC (Joel Greenblatt) % is 5.52%, which is 309% above median its 10-year median of 1.35 and 33.2% above the Medical Devices & Instruments industry median of 4.15. PT Maja Agung Latexindo Tbk's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For PT Maja Agung Latexindo Tbk (ISX:SURI), the current ROC (Joel Greenblatt) % is 5.52% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Maja Agung Latexindo Tbk specializes in the production of latex gloves, made from natural rubber, and is a primary choice in the medical and industrial sectors. The company's business includes business of making rubber goods for health support needs, such as contraceptive gloves (birth control)/ condoms, pacifiers and compresses, medical rubber gloves, and urinary catheters (folley catheter). Its segments include Gloves and Concentrated latex.
28GF Score
Get the complete analysis for ISX:SURI
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SURI has been successfully added to your 
